Showing results (131-140 of 181) with videos related to
Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology|October 3, 2009
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiencyFleur Bossi, Fabio Fischetti, Domenico Regoli, et al.Medicine|March 5, 2015
Clinical and pathological findings of a fatal systemic capillary leak syndrome (Clarkson disease): a case reportAndrea Zancanaro, Francesco Serafini, Giuseppe Fantin, et al.Internal and Emergency Medicine|May 19, 2011
Lung ultrasonography for the assessment of rapid extravascular water variation: evidence from hemodialysis patientsMatteo Trezzi, Daniela Torzillo, Elisa Ceriani, et al.The New England Journal of Medicine|September 8, 2010
Ecallantide for the treatment of acute attacks in hereditary angioedemaMarco Cicardi, Robyn J Levy, Donald L McNeil, et al.The American Journal of Medicine|July 4, 2012
Clinical impact of peripheral attacks in hereditary angioedema patientsAndy Kusuma, Anurag Relan, André C Knulst, et al.Plos One|November 7, 2017
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunctionMaddalena A Wu, Francesco Casella, Francesca Perego, et al.Transfusion|November 26, 2013
Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION studyInmaculada Martinez-Saguer, Marco Cicardi, Chiara Suffritti, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 12, 2020
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trialDonald S Levy, Henriette Farkas, Marc A Riedl, et al.Journal of Clinical Medicine|October 29, 2020
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 InhibitorGedeon Loules, Faidra Parsopoulou, Maria Zamanakou, et al.CPT: Pharmacometrics & Systems Pharmacology|January 10, 2018
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary AngioedemaYing Zhang, Michael A Tortorici, Dipti Pawaskar, et al.Pageof 19